Melodi Health Announces $10.75 Million in Series A Funding, First Enrollment in Pivotal Clinical Trial Katie Lew · August 29, 2024
August 29, 2024 Melodi Health Announces $10.75 Million in Series A Funding, First Enrollment in Pivotal Clinical TrialGround-breaking investigational product from Melodi Health is designed to reduce post-surgical infections
August 27, 2024 NeuraWorx Partners with Corundum Neuroscience to Initiate Clinical Feasibility Study, Develop Innovative Neurological Disease TreatmentEXCELSIOR, Minn. – Aug. 27, 2024 – PRLog — NeuraWorx Medical Technologies, Inc., a neurotechnology therapeutics company, announced
August 27, 2024 Biocoat Incorporated Secures New Patent for Non-PFAS Inner Diameter CoatingHorsham, PA, [August 27, 2024] – Biocoat Incorporated, a leader in the
NewsIn the Know: Healthcare News for July 1, 2024 Katie LewJuly 1, 2024 In the Know: Healthcare News for July 1, 2024
NewsSTERIS Announces Completion of Libertyville, Illinois Expansion to Include X-Ray Processing Katie LewJune 27, 2024 STERIS Announces Completion of Libertyville, Illinois Expansion to Include X-Ray Processing
News, Press ReleaseAllina Health Celebrates New Center for Mental Health and Addiction with Ribbon-Cutting Ceremony Katie LewJune 27, 2024 Allina Health Celebrates New Center for Mental Health and Addiction with Ribbon-Cutting Ceremony
NewsUroMems Raises Record $47 million (€44 Million) in Series C Financing to Fund Pivotal Clinical Trials of the UroActive™ System, the First Smart Automated Implant to Treat Stress Urinary Incontinence Katie LewJune 25, 2024 UroMems Raises Record $47 million (€44 Million) in Series C Financing to Fund Pivotal Clinical Trials of the UroActive™ System, the First Smart Automated Implant to Treat Stress Urinary Incontinence